DALLAS - December 15, 2009 - Hadassah Lieberman has long been associated with Susan G. Komen for the Cure®, working with us on breast cancer education and awareness in other countries as a Susan G. Komen Global Ambassador. Her efforts have been invaluable and we intend to keep tapping her expertise to fulfill our goal to bring breast cancer programs to women in countries who have few resources to battle this disease.
Mrs. Lieberman’s efforts on our behalf are separate and unrelated to our advocacy on health reform. The Susan G. Komen for the Cure Advocacy Alliance, the sister organization of Susan G. Komen for the Cure, has been working hard to support health care reforms that protect breast cancer patients and survivors from high-out-of pocket costs, prevent discrimination against people with pre-existing conditions and ensure access to cancer screening and treatment.
It’s been reported that Susan G. Komen for the Cure provides funding to pharmaceutical companies. That is simply not true. We have never funded pharmaceutical company research – our grants, totaling $450 million, have gone to research institutions in the U.S. and abroad. Another $900 million in Susan G. Komen for the Cure funding has gone to programs in communities world-wide. We will commit another $50 million to research in the coming year.
Related articles:
The anti-feminist attack on Hadassah Lieberman - Washington Post (December 16, 2009)
